EXPRESSION OF CYCLIN D1 IN VARYING GRADES OF ORAL SQUAMOUS CELL CARCINOMA: AN IMMUNOHISTOCHEMICAL STUDY

RUBEENA ANJUM; Mohd Hussain; MANDEEP KAUR; NIDHI KHAJURIA

doi:10.22159/ajpcr.2023.v16i6.47282

Authors

RUBEENA ANJUM Department of Oral and Maxillofacial Pathology and Oral Microbiology, IGGDC, Jammu, Jammu and Kashmir, India.
Mohd Hussain Department of Oral and Maxillofacial Pathology and Oral Microbiology, IGGDC, Jammu, Jammu and Kashmir, India.
MANDEEP KAUR Department of Oral and Maxillofacial Pathology and Oral Microbiology, IGGDC, Jammu, Jammu and Kashmir, India.
NIDHI KHAJURIA Department of Oral and Maxillofacial Pathology and Oral Microbiology, IGGDC, Jammu, Jammu and Kashmir, India.

DOI:

https://doi.org/10.22159/ajpcr.2023.v16i6.47282

Keywords:

Cyclin D1, OSCC, G1-S transition, Immunohistochemistry

Abstract

Objective: Cyclin D1 promotes cell cycle progression during G1 phase, a key event in G1-S transition. It is a positive regulator of cell cycle. Overexpression may lead to disturbance in normal cell cycle control and tumor formation. The objective of the study was to evaluate the expression of cyclin D1 in varying grades of oral squamous cell carcinoma (OSCC).

Methods: Nine formalin-fixed paraffin embedded tissues were immunohistochemically analyzed for the expression of cyclin D1 in varying grades of OSCC.

Results: Expression of cyclin D1 was more in poorly differentiated OSCC than moderately and well-differentiated OSCC.

Conclusion: Increased expression of cyclin D1 was seen in poorly differentiated OSCC and thus can be used as a biomarker for the aggressiveness of OSCC.

Downloads

Download data is not yet available.

References

Feller L, Lemmer J. Oral squamous cell carcinoma: Epidemiology, clinical presentation and treatment. J Cancer Ther 2012;3:263-8. doi: 10.4236/jct.2012.34037

Pindborg J, Reichart P, Smith C, Waal IV. Precancerous conditions. In: World Health Organization, editor. Histological Typing of Cancer and Pre-cancer of the Oral Mucosa. 2nd ed. Berlin: Springer; 1997. p. 1-87.

Hussain M, Anjum R, Kaur M, Khajuria N, Bhat N, Bhardwaj A. Oral cancer awareness among non-medical professionals-a cross-sectional study in Ladakh. Int J Adv Res 2021;9:263-70. doi: 10.21474/ IJAR01/13738

Moharil RB, Khandekar S, Dive A, Bodhade A. Cyclin D1 in oral premalignant lesions and oral squamous cell carcinoma: An immunohistochemical study. J Oral Maxillofac Pathol 2020;24:397. doi: 10.4103/jomfp.JOMFP_164_20, PMID 33456254

Patel SB, Manjunatha BS, Shah V, Soni N, Sutariya R. Immunohistochemical evaluation of p63 and cyclin D1 in oral squamous cell carcinoma and leukoplakia. J Korean Assoc Oral Maxillofac Surg 2017;43:324-30. doi: 10.5125/jkaoms.2017.43.5.324, PMID 29142867

Choudhary A, Kesarwani P, Gaikwad P, Hiremath SS, Gupta R, Koppula SK. Expression of cyclin D1 in oral squamous cell carcinoma and its correlation with histological differentiation: An immunohistochemical study. J Indian Acad Oral Med Radiol 2016;28:140-4. doi: 10.4103/0972-1363.195099

Angadi PV, Krishnapillai R. Cyclin D1 expression in oral squamous cell carcinoma and verrucous carcinoma: Correlation with histological differentiation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:e30-5. doi: 10.1016/j.tripleo.2006.09.011, PMID 17197212

Wang S, Lloyd RV, Hutzler MJ, Safran MS, Patwardhan NA, Khan A. The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer. Mod Pathol 2000;13:882-7. doi: 10.1038/ modpathol.3880157, PMID 10955455

Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. Minireview: Cyclin D1: Normal and abnormal functions. Endocrinology 2004;145:5439-47. doi: 10.1210/en.2004-0959, PMID 15331580

Montalto FI, De Amicis FD. Cyclin D1 in cancer: A molecular connection for cell cycle control, adhesion and invasion in tumor and stroma. Cells 2020;9:2648. doi: 10.3390/cells9122648

Chen S, Li L. Degradation strategy of cyclin D1 in cancer cells and the potential clinical application. Front Oncol 2022;12:949688. doi: 10.3389/fonc.2022.949688, PMID 36059670

Lam KY, Ng IO, Yuen AP, Kwong DL, Wei W. Cyclin D1 expression in oral squamous cell carcinomas: Clinico-pathological relevance and correlation with p53 expression. J Oral Pathol Med 2000;29:167-72. doi: 10.1034/j.1600-0714.2000.290404.x, PMID 10766394

Saawarn S, Astekar M, Saawarn N, Dhakar N, Sagari SG. Cyclin D1 expression and its correlation with histopathological differentiation in oral squamous cell carcinoma. Sci World J 2012;2012:978327.

Gatoo MA, Dar AM. Cyclin D1 expression of different histological grades in oral squamous cell carcinoma patients from Northern India. Arch Oncol 2018;24:6-9. doi: 10.2298/AOO180312001G

Huang SF, Cheng SD, Chuang WY, Chen IH, Liao CT, Wang HM, et al. Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma. World J Surg Oncol 2012;10:40. doi: 10.1186/1477-7819-10-40, PMID 22336657

Fatima S, Hosein M, Butt SK, Baig F, Siddiqui RA, Abidi F. Immunohistochemical analysis of expression of cyclin D1 in different grades oral squamous cell carcinoma. J Pharm Res 2022;34:7-12.